Superiority of letrozole over tamoxifen in the first-line treatment of metastatic breast cancer patients with normal serum Her-2/neu levels: question of tamoxifen resistance.

K. Altundağ,O. Altundag
DOI: https://doi.org/10.1200/JCO.2003.99.152
IF: 45.3
2003-12-15
Journal of Clinical Oncology
Abstract:
What problem does this paper attempt to address?